Crossmark

Defining the impact of adjuvant treatment on the prognosis of patients with inoperable glioblastoma undergoing biopsy only: does the survival benefit outweigh the treatment effort?

Crossref DOI link: https://doi.org/10.1007/s10143-022-01754-y

Published Online: 2022-02-23

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Löber-Handwerker, Ronja

Döring, Katja

Bock, Christoph

Rohde, Veit

Malinova, Vesna https://orcid.org/0000-0002-0062-7490
Funding

Funding for this research was provided by:

Georg-August-Universität Göttingen
License Information

Text and Data Mining valid from 2022-02-23

Version of Record valid from 2022-02-23
More Information

Article History

Received: 21 December 2021

Revised: 5 February 2022

Accepted: 10 February 2022

First Online: 23 February 2022

Declarations

:

: The study was approved by the local ethics committee of the University Medicine Göttingen (Study identification number 16/12/20). Due to the retrospective nature of the study, informed consent was deemed not necessary and all the procedures being performed were part of the routine care. All procedures performed in this study were in accordance with the ethical standards of institutional and/ or national research committee and with the 1964 Helsinki Declaration.

: Due to retrospective nature of the study, informed consent was waived.

: Due to the retrospective nature of the study, informed consent was waived.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below